USFDA approves AstraZeneca diabetes drug for treating heart failure risk

USFDA approves AstraZeneca diabetes drug for treating heart failure risk The approval by the U.S. Food and Drug Administration is based on results from the DECLARE-TIMI 58 clinical trial, the London-listed company said, and follows a similar approval by the European authorities in August.

from Moneycontrol World News https://ift.tt/2MWmCQE
USFDA approves AstraZeneca diabetes drug for treating heart failure risk USFDA approves AstraZeneca diabetes drug for treating heart failure risk Reviewed by VidhanSabha on October 21, 2019 Rating: 5

No comments:

AD now

loading...
Powered by Blogger.